- $63.30m
- $62.52m
- $144.50m
- 31
- 58
- 71
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18 | 44.9 | 64.7 | 93.2 | 145 |
Cost of Revenue | |||||
Gross Profit | 0.781 | 0.962 | 1.53 | 1.79 | 4.67 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 18.7 | 48.3 | 68.2 | 96.4 | 145 |
Operating Profit | -0.669 | -3.37 | -3.51 | -3.19 | -0.316 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.44 | -6.7 | -3.86 | -5.87 | -0.219 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.44 | -6.7 | -3.86 | -5.87 | -0.219 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -5.46 | -6.57 | -3.84 | -5.97 | -0.763 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.46 | -6.57 | -3.84 | -5.97 | -1.58 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.348 | -0.1 | -0.024 | -0.036 | -0.008 |